http://pawarlawgroup.com/cases/cancer-genetics-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Cancer Genetics had ineffective disclosure controls and internal controls over financial reporting; and (2) as a result, Defendants' statements about the Company's business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 4, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/cancer-genetics-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll-free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 500152

"/> CGIX DEADLINE: Pawar Law Reminds Investors of Important June 4, 2018 Lead Plaintiff Deadline in Class Action- CGIX « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
Great News! MarketersMedia is officially entering into a long-term partnership with Vertical News Network.
Learn More
How It Works? Plans & Pricing Our Distributions Newsroom Info Hub Sign Up Sign In Send Press Release Contact Sales
Contact Sales Sign Up Your Account Send Press Release
MarketersMEDIA / Newsroom / CGIX DEADLINE: Pawar Law Reminds Investors of Important June 4, 2018 Lead Plaintiff Deadline in Class Action- CGIX

CGIX DEADLINE: Pawar Law Reminds Investors of Important June 4, 2018 Lead Plaintiff Deadline in Class Action- CGIX

Share This Press Release

NEW YORK, NY / ACCESSWIRE / May 17, 2018 / Pawar Law Group reminds shareholders who purchased shares of Cancer Genetics, Inc. (NASDAQ: CGIX) from March 23, 2017 through April 2, 2018, both dates inclusive ("Class Period") of the important June 4, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Cancer Genetics investors under the federal securities laws. To join the Cancer Genetics class action, go to http://pawarlawgroup.com/cases/cancer-genetics-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Cancer Genetics had ineffective disclosure controls and internal controls over financial reporting; and (2) as a result, Defendants' statements about the Company's business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 4, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/cancer-genetics-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll-free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 500152

NEW YORK, NY / ACCESSWIRE / May 17, 2018 / Pawar Law Group reminds shareholders who purchased shares of Cancer Genetics, Inc. (NASDAQ: CGIX) from March 23, 2017 through April 2, 2018, both dates inclusive ("Class Period") of the important June 4, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Cancer Genetics investors under the federal securities laws. To join the Cancer Genetics class action, go to http://pawarlawgroup.com/cases/cancer-genetics-inc/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email vik@pawarlawgroup.com for information on the class action.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. You may also remain an absent class member and do nothing at this point. You may retain counsel of your choice.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Cancer Genetics had ineffective disclosure controls and internal controls over financial reporting; and (2) as a result, Defendants' statements about the Company's business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 4, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://pawarlawgroup.com/cases/cancer-genetics-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll-free at 888-589-9804 or via email at vik@pawarlawgroup.com.

Pawar Law Group represents investors from around the world.

Contact:

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

SOURCE: Pawar Law Group

ReleaseID: 500152

Source URL: https://marketersmedia.com/cgix-deadline-pawar-law-reminds-investors-of-important-june-4-2018-lead-plaintiff-deadline-in-class-action-cgix/346872

Source: AccessWire

Release ID: 346872

Our Client

Subscribe and Recieve exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2018 MarketersMedia – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).